IsamDiabMD

Rheumatology • Cleveland, OH

Rheumatoid Arthritis & Related

Physician

Join to view full profile

Dr. Diab is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Diab's full profile

Already have an account?

Office
18660 Bagley Road
#102b
Cleveland, OH 44130
Phone+1 440-891-9395

Fax+1 440-891-1765
Is this information wrong?

Education & Training

The MetroHealth System/Case Western Reserve UniversityFellowship, Rheumatology, 1990 - 1992
Cleveland Clinic Foundation/Fairview HospitalResidency, Internal Medicine, 1987 - 1990
University of Aleppo Faculty of MedicineClass of 1978

Certifications & Licensure

CA State Medical License 1989 - Present
OH State Medical License 1990 - 2025
American Board of Internal Medicine Rheumatology
certified clinical bone density interpreterCCD
CPICertified Principal Investigator

Awards, Honors, & Recognition

Fellow (FACR) American College of Rheumatology

Clinical Trials

Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease Start of enrollment: 2013 Mar 18
Terminated
Phase 2
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2013 Jun 27
Completed
Phase 3
Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2012 Jun 01
Completed
Phase 2
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus Start of enrollment: 2014 Jan 01
Terminated
Phase 3
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) Start of enrollment: 2020 Jul 01
Recruiting
Phase 3
Roles: Contact
Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2) Start of enrollment: 2020 Jul 01
Active, not recruiting
Phase 3
Roles: Contact
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis Start of enrollment: 2022 Jun 30
Recruiting
Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

14 citations
Selective expansion of regulatory T cells by NKTR-358 in healthy volunteers and patients with systemic lupus erythematosus.
Christie Fanton, Richard Furie, Vishala Chindalore, Robert Levin, Isam Diab, Neha Dixit, Cat Haglund, Jacqueline Gibbons, Nathan Hanan, Daniel Dickerson, Jonathan Zale...> ;Journal of Translational Autoimmunity. 2022 Jan 1

Professional Memberships

American College of Rheumatology - ACR
Fellow

Hospital Affiliations

University Hospitals St. John Medical CenterWestlake, Ohio
Cleveland Clinic Fairview HospitalCleveland, Ohio
Lakewood HospitalLakewood, Ohio
Southwest General Health CenterCleveland, Ohio